CAS: 1480833-70-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PF-04885614 REF: TM-T12421CAS: 1480833-70-2 | 98.02% | 48.00 €~1,568.00 € | Wed 16 Apr 25 |
 | PF 04885614 REF: IN-DA01LRELCAS: 1480833-70-2 | 97% | 114.00 €~341.00 € | Wed 16 Apr 25 |
 | PF-04885614 REF: 54-BUP08544CAS: 1480833-70-2 | 98.01% | 429.00 €~2,122.00 € | Thu 17 Apr 25 |
 | PF 04885614 REF: 3D-FJC83370CAS: 1480833-70-2 | Min. 95% | To inquire | Wed 28 May 25 |
PF-04885614
CAS:1480833-70-2
PF-04885614 is a potent inhibitor of NaV1.8, has potential for neurological and neurodevelopmental diseases treatment.
Formula:
C13H14F3N3O
Purity:
98.02%
Color and Shape:
Solid
Molecular weight:
285.27
Ref: TM-T12421
| 1mg | 48.00 € | ||
| 2mg | 65.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 153.00 € | ||
| 25mg | 283.00 € | ||
| 50mg | 527.00 € | ||
| 100mg | 743.00 € | ||
| 500mg | 1,568.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
PF 04885614
CAS:1480833-70-2
Formula:
C13H14F3N3O
Purity:
97%
Color and Shape:
Solid
Molecular weight:
285.265
Ref: IN-DA01LREL
| 5mg | 114.00 € | ||
| 10mg | 122.00 € | ||
| 25mg | 162.00 € | ||
| 50mg | 154.00 € | ||
| 100mg | 202.00 € | ||
| 250mg | 341.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ref: 54-BUP08544
| 25mg | 429.00 € | ||
| 50mg | 788.00 € | ||
| 100mg | 1,092.00 € | ||
| 500mg | 2,122.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025
PF 04885614
CAS:1480833-70-2
Please enquire for more information about PF 04885614 including the price, delivery time and more …
Formula:
C13H14F3N3O
Purity:
Min. 95%
Molecular weight:
285.26 g/mol
Ref: 3D-FJC83370
| 25mg | 902.00 € | ||
| 50mg | 1,360.00 € | ||
| 100mg | 1,892.00 € |
Estimated delivery in United States, on Wednesday 28 May 2025
